CAPRIN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.67084182232247E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.26951790693874E-12 |
Normal-vs-Stage2 |
3.62259999997505E-07 |
Normal-vs-Stage3 |
2.30571117754153E-12 |
Normal-vs-Stage4 |
3.06520000492583E-08 |
Stage1-vs-Stage2 |
6.581200E-01 |
Stage1-vs-Stage3 |
2.519700E-02 |
Stage1-vs-Stage4 |
2.402400E-01 |
Stage2-vs-Stage3 |
2.676800E-01 |
Stage2-vs-Stage4 |
5.573200E-01 |
Stage3-vs-Stage4 |
7.184000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.53330689758968E-12 |
Normal-vs-AfricanAmerican |
1.74189551671589E-11 |
Normal-vs-Asian |
9.765700E-02 |
Caucasian-vs-AfricanAmerican |
3.948200E-02 |
Caucasian-vs-Asian |
3.704800E-01 |
AfricanAmerican-vs-Asian |
7.725600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.8475446707007E-13 |
Normal-vs-Female |
3.27029514579635E-11 |
Male-vs-Female |
2.416800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.39549999999844E-05 |
Normal-vs-Age(41-60Yrs) |
9.13570330496327E-11 |
Normal-vs-Age(61-80Yrs) |
2.59825494453025E-12 |
Normal-vs-Age(81-100Yrs) |
1.90710000014249E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.408200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.334000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.523600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.118200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.034200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.550600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.424000E-02 |
Normal-vs-Grade 2 |
3.08509995328166E-10 |
Normal-vs-Grade 3 |
1.63569158218024E-12 |
Normal-vs-Grade 4 |
1.55229999965201E-08 |
Grade 1-vs-Grade 2 |
4.129600E-01 |
Grade 1-vs-Grade 3 |
9.507600E-02 |
Grade 1-vs-Grade 4 |
3.080100E-02 |
Grade 2-vs-Grade 3 |
2.021800E-02 |
Grade 2-vs-Grade 4 |
7.967900E-02 |
Grade 3-vs-Grade 4 |
6.217600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.26560004090715E-09 |
Normal-vs-ccB subtype |
1.12539977337178E-11 |
ccA subtype-vs-ccB subtype |
8.982800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.19959997491037E-09 |
Normal-vs-N1 |
2.210700E-04 |
N0-vs-N1 |
4.344600E-01 |
|
|